T-cell subpopulations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis: A follow-up study

Neurology

Volumn 47, Issue 6, 1996, Pages 1542-1545

  Oksaranta, O ^a   Tarvonen, S ^a   Ilonen, J ^a   Poikonen, K ^b   Reunanen, M ^b   Panelius, M ^a   Salonen, R ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOTROPIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PLACEBO; PREDNISOLONE;

ARTICLE; BLOOD; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING DISEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATORY DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE SUBPOPULATION;

EID: 0029731440     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1542     Document Type: Article

References (37)

1. Antel JP, Bania MB, Reder A. Activated suppressor cell dysfunction in progressive multiple sclerosis. J Immunol 1986; 137:137-141.
2. Chofflon M, Weiner HL, Morimoto C, Hafler D. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+2H4+) T cells in multiple sclerosis. Ann Neurol 1988;24:185-191.
3. Freedman MS, Ruijs TCG, Blain M, Antel JP. Phenotypic and functional characteristics of activated CD8+ cells: a CD11b-CD28- subset mediates noncytolytic functional suppression. Clin Immun Immunopathol 1991;60:254-267.
4. Antel JP, Freedman MS, Brodovsky S, Francis GS, Duquette P. Activated suppressor cell function in severely disabled patients with multiple sclerosis. Ann Neurol 1989;25:204-207.
5. Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF. The isolation and characterisation of the human suppressor inducer T cell subset. J Immunol 1985;134:1508-1515.
6. Morimoto C, Steinberg AD, Letvin LN, et al. A defect of immunoregulatory T cell subsets in SLE patients demonstrated with anti-2H4 antibody. J Clin Invest 1987;79:762-768.
7. Rose LM, Ginsberg AH, Rothstein TL, Ledbetter JA, Clark EA. Selective loss of a subset of T helper cells in active multiple sclerosis. Proc Natl Acad Sci USA 1985;82:7389-7393.
8. Rose LM, Ginsberg AH, Rothstein TL, Ledbetter JA, Clark EA. Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol 1988;24:192-199.
9. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T-cells: reinterpretation of helper inducer and suppressor-inducer subsets. Immunol Today 1988;9:195-199.
10. Tedder TF, Cooper MD, Clement LT. Human lymphocyte differentiation antigens HB-10 and HB-11. II. Differential production of B cell growth and differentiation factors by distinct helper cell subpopulations. J Immunol 1985;134:2989-2994.
11. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990;348:163-166.
12. Chofflon M, Weiner HL, Morimoto C, Hafler DA. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 1989;25:494-499.
13. Salonen R, Ilonen J, Jägerroos H, Syrjälä H, Nurmi T, Reunanen M. Lymphocyte subsets in the cerebrospinal fluid in active multiple sclerosis. Ann Neurol 1989;25:500-502.
14. Matsui M, Mori KJ, Saida T. Cellular immunoregulatory mechanisms in the central nervous system: characterisation of noninflammatory and inflammatory cerebrospinal fluid lymphocytes. Ann Neurol 1990;27:647-651.
15. Zaffaroni M, Gallo L, Ghezzi A, Cazzullo CL. CD4+ lymphocyte subsets in the cerebrospinal fluid of multiple sclerosis and non-inflammatory neurological diseases. J Neurol 1991; 238:209-211.
16. Hayashi T, Morimoto C, Burks JS, et al. Double-label immunochemical analysis of T-cell activation markers and MCH expression in active multiple sclerosis lesions. J Neuroimmunol 1987;16:74.
17. Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988;140:2210-2214.
18. Pitzalis C, Kingsley G, Haskard D, Panayi G. The preferential accumulation of helper-inducer T-lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988;18:1397-1404.
19. Newman I, Wilkinson PC. Locomotor responses of human CD45 lymphocyte subsets: preferential locomotion of CD45RO+ lymphocytes in response to attractants and mitogens. Immunology 1993;78:92-98.
20. Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF. Loss of suppressor T cells in active multiple sclerosis. N Engl J Med 1980;303:125-129.
21. Weiner HL, Hafler DA, Fallis RJ, Johnson D, Ault KA, Hauser SL. Altered blood T-cell subsets in patients with multiple sclerosis. J Neuroimmunol 1984;6:115-121.
22. Hughes PJ, Kirk PF, Compston DAS. Dual labelling of circulating CD8 cells in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:118-121.
23. Stark E. T-cell subsets in the cerebrospinal fluid in the course of inflammatory neurological diseases. J Neuroimmunol 1988; 20:259-260.
24. Kastrukoff LF, Paty DW. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis. Ann Neurol 1984;15:250-256.
25. Rice GPA, Finney D, Braheny SL, Knobler RL, Sipe JC, Oldstone MBA. Disease activity markers in multiple sclerosis: another look at suppressor cells defined by monoclonal antibodies OKT4 and OKT8. J Neuroimmunol 1984;6:75-84.
26. Cashman N, Martin D, Eizembaum J-F, Degos J-D, Bach M-A. Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid. J Clin Invest 1982;70: 387-392.
27. Antonen J, Syrjälä P, Oikarinen R, Frey H, Krohn K. Acute multiple sclerosis exacerbations are characterized by low cerebrospinal fluid suppressor/cytotoxic T-cells. Acta Neurol Scand 1987;75:156-160.
28. Zaffaroni M, Caputo D, Ghezzi A, Cazzullo CL. T-cell subsets in multiple sclerosis: relationships between peripheral blood and cerebrospinal fluid. Acta Neurol Scand 1985;71:242-248.
29. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 1986;19:578-587.
30. McCallum K, Esiri MM, Tourtellotte WW, Boos J. T cell subsets in multiple sclerosis: gradients at plaque borders and differences in nonplaque regions. Brain 1987;110:1297-1308.
31. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. J Neurol Sci 1986;74:135-152.
32. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
33. Morimoto C, Hafler DA, Weiner HL, et al. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. N Engl J Med 1987;316:67-72.
34. Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period. Ann Neurol 1983;13:418-425.
35. Reinherz EL, Schlossman SF. Regulation of the immune response: inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 1980;303:370-373.
36. Hirsch RL, Ordonez J, Panitch HS, Johnson KP. T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis. J Neuroimmunol 1985;9:391-398.
37. Kirk P, Compston A. The effect of methylprednisolone on lymphocyte phenotype and function in patients with multiple sclerosis. J Neuroimmunol 1990;26:1-8.